Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery
Alliance
-
-
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
-
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
-
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
-
Irinotecan and Cetuximab in Treating Patients With Metastatic Breast Cancer
-
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
-
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
-
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
-
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma
-
Surgery in Treating Patients With Prostate Cancer
Categories
Alliance Committee
Browse by Year